Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		71,115,000
Beginning balance at Dec. 31, 2021	$ 276,129	$ 711	$ 4,096,402	$ (2,911)	$ (3,818,073)
Ending balance (in shares) at Mar. 31, 2022	71,438,000
Beginning balance (in shares) at Dec. 31, 2021		71,115,000
Beginning balance at Dec. 31, 2021	$ 276,129	$ 711	4,096,402	(2,911)	(3,818,073)
Ending balance (in shares) at Jun. 30, 2022	73,551,000
Beginning balance (in shares) at Dec. 31, 2021		71,115,000
Beginning balance at Dec. 31, 2021	$ 276,129	$ 711	4,096,402	(2,911)	(3,818,073)
Ending balance (in shares) at Sep. 30, 2022	82,880,000
Beginning balance (in shares) at Dec. 31, 2021		71,115,000
Beginning balance at Dec. 31, 2021	$ 276,129	$ 711	4,096,402	(2,911)	(3,818,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		979,000
Vesting of restricted stock units	0	$ 10	(10)
Exercise of stock options (in shares)		7,000
Exercise of stock options	16		16
Purchase of common stock under ESPP (in shares)		68,000
Purchase of common stock under ESPP	239	$ 1	238
Stock-based compensation	35,382		35,382
Issuance of common stock (in shares)		10,742,000
Issuance of common stock	54,067	$ 107	53,960
Issuance of unrestricted stock awards to settle accrued employee compensation (in shares)		12,000
Issuance of unrestricted stock awards to settle accrued employee compensation	1	$ 1
Other comprehensive gain (loss)	(1,159)			(1,159)
Net loss	$ (230,342)				(230,342)
Ending balance (in shares) at Dec. 31, 2022	82,923,000	82,923,000
Ending balance at Dec. 31, 2022	$ 134,333	$ 830	4,185,988	(4,070)	(4,048,415)
Beginning balance (in shares) at Mar. 31, 2022	71,438,000
Ending balance (in shares) at Jun. 30, 2022	73,551,000
Ending balance (in shares) at Sep. 30, 2022	82,880,000
Beginning balance (in shares) at Dec. 31, 2022	82,923,000	82,923,000
Ending balance (in shares) at Mar. 31, 2023	106,370,000
Beginning balance (in shares) at Dec. 31, 2022	82,923,000	82,923,000
Beginning balance at Dec. 31, 2022	$ 134,333	$ 830	4,185,988	(4,070)	(4,048,415)
Ending balance (in shares) at Jun. 30, 2023	106,454,000
Beginning balance (in shares) at Dec. 31, 2022	82,923,000	82,923,000
Beginning balance at Dec. 31, 2022	$ 134,333	$ 830	4,185,988	(4,070)	(4,048,415)
Ending balance (in shares) at Sep. 30, 2023	107,022,000
Beginning balance (in shares) at Dec. 31, 2022	82,923,000	82,923,000
Beginning balance at Dec. 31, 2022	$ 134,333	$ 830	4,185,988	(4,070)	(4,048,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		1,092,000
Vesting of restricted stock units	$ (196)	$ 10	(206)
Exercise of stock options (in shares)	3,000	24,000
Exercise of stock options	$ 92		92
Purchase of common stock under ESPP (in shares)		135,000
Purchase of common stock under ESPP	429	$ 2	427
Stock-based compensation	21,151		21,151
Issuance of common stock (in shares)		106,333,000
Issuance of common stock	248,367	$ 1,063	247,304
Exercise of warrants (in shares)		2,265,000
Other comprehensive gain (loss)	2,274			2,274
Net loss	$ (211,913)				(211,913)
Ending balance (in shares) at Dec. 31, 2023	192,772,000	192,772,000
Ending balance at Dec. 31, 2023	$ 194,537	$ 1,905	$ 4,454,756	$ (1,796)	$ (4,260,328)
Beginning balance (in shares) at Mar. 31, 2023	106,370,000
Ending balance (in shares) at Jun. 30, 2023	106,454,000
Ending balance (in shares) at Sep. 30, 2023	107,022,000